Literature DB >> 20555108

Familial colorectal cancer risk: ESMO Clinical Practice Guidelines.

J Balmaña1, A Castells, A Cervantes.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20555108     DOI: 10.1093/annonc/mdq169

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  17 in total

1.  Targeted next generation sequencing screening of Lynch syndrome in Tunisian population.

Authors:  Rihab Ben Sghaier; Anne Maria Lucia Jansen; Ahlem Bdioui; Tom Van Wezel; Mehdi Ksiaa; Lamia Elgolli; Leila Ben Fatma; Slim Ben Ahmed; Mohamed Msaddak Azzouz; Olfa Hellara; Amine Elghali; Fathi Darbel; Karim Skandrani; Moncef Mokkni; Ameni Gdissa; Rached Ltaief; Ali Saad; Fahmi Hmila; Moez Gribaa; Hans Morreau
Journal:  Fam Cancer       Date:  2019-07       Impact factor: 2.375

Review 2.  Choosing the optimal method in programmatic colorectal cancer screening: current evidence and controversies.

Authors:  Antoni Castells
Journal:  Therap Adv Gastroenterol       Date:  2015-07       Impact factor: 4.409

Review 3.  Multiple primary colorectal cancer: Individual or familial predisposition?

Authors:  José A Pajares; José Perea
Journal:  World J Gastrointest Oncol       Date:  2015-12-15

Review 4.  Adjuvant therapy for early colon cancer: current status.

Authors:  Alexander Stein; Sonja Hiemer; Hans-Joachim Schmoll
Journal:  Drugs       Date:  2011-12-03       Impact factor: 9.546

5.  Colorectal cancer survivors' interest in genetic testing for hereditary cancer: implications for universal tumor screening.

Authors:  Deborah Cragun; Teri L Malo; Tuya Pal; David Shibata; Susan T Vadaparampil
Journal:  Genet Test Mol Biomarkers       Date:  2012-01-06

Review 6.  Early-onset colorectal cancer: a separate subset of colorectal cancer.

Authors:  Irene Osorio Silla; Daniel Rueda; Yolanda Rodríguez; Juan Luis García; Felipe de la Cruz Vigo; José Perea
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

7.  Exploring clinicians' attitudes about using aspirin for risk reduction in people with Lynch Syndrome with no personal diagnosis of colorectal cancer.

Authors:  Yanni Chen; Michelle Peate; Rajneesh Kaur; Bettina Meiser; Tim Wong; Judy Kirk; Robyn L Ward; Annabel Goodwin; Finlay Macrae; Janet Hiller; Alison H Trainer; Gillian Mitchell
Journal:  Fam Cancer       Date:  2017-01       Impact factor: 2.375

Review 8.  Familial colorectal cancer type X: genetic profiles and phenotypic features.

Authors:  Mev Dominguez-Valentin; Christina Therkildsen; Sabrina Da Silva; Mef Nilbert
Journal:  Mod Pathol       Date:  2014-04-18       Impact factor: 7.842

9.  Cancer risk assessment using genetic panel testing: considerations for clinical application.

Authors:  Susan Hiraki; Erica S Rinella; Freya Schnabel; Ruth Oratz; Harry Ostrer
Journal:  J Genet Couns       Date:  2014-03-07       Impact factor: 2.537

10.  Genetic testing strategies in newly diagnosed endometrial cancer patients aimed at reducing morbidity or mortality from lynch syndrome in the index case or her relatives.

Authors:  Alison Stewart
Journal:  PLoS Curr       Date:  2013-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.